Wikidata

(Q63807720)

English

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tazemetostat in Patients With Tumors Harboring Alterations in EZH2 or Members of the SWI/SNF Complex (English)
0 references
medical condition
lymphoma
0 references
sarcoma
0 references
glioma
0 references
neuroblastoma
0 references
osteosarcoma
0 references
rhabdomyosarcoma
0 references
ependymoma
0 references
medulloblastoma
0 references
histiocytosis
0 references
hepatoblastoma
0 references
start time
24 July 2017
0 references
end time
30 September 2024
0 references
number of participants
49
0 references
research site
Loma Linda University
0 references
Yale University
0 references
University of Miami
0 references
University of Chicago
0 references
Mayo Clinic
0 references
Mission Health System
0 references
Cleveland Clinic
0 references
Vanderbilt University
0 references
minimum age
12 month
0 references
maximum age
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63807720&oldid=2235174506"